Showing results out of
The Kowalinski group at EMBL Grenoble identified significant differences between the trypanosomal and human nuclear cap-binding complex, a key player in cellular RNA metabolism and a potential target for novel anti-parasitic drugs.
SCIENCE & TECHNOLOGY2025
science-technology
EMBL Grenoble’s Kowalinski Group analysed the structure of an enzyme responsible for modifying tRNA molecules to fine-tune protein production. They discovered that to distinguish almost identical, yet different, tRNA molecules, the enzyme uses help from another enzyme – a type of cooperation…
SCIENCE & TECHNOLOGY2024
science-technology
Rutuja Yelmar, predoctoral Fellow at EMBL Grenoble in the Kowalinski group, talks about her passion for research, daily inspiration, and the importance of collaboration in achieving her goals.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectives
This single-celled organism the size of a dust particle is capable of causing deadly tropical diseases in both humans and livestock –Trypanosoma brucei, in an image by Luciano Dolce from EMBL.
LAB MATTERSSCIENCE & TECHNOLOGY2023
lab-matterspicture-of-the-weekscience-technology
EMBL Grenoble scientists provide new insights into the function of an essential RNA editing enzyme.
SCIENCE & TECHNOLOGY2023
sciencescience-technology
Members of the EMBL community are working to improve our understanding of the parasites that cause malaria and sleeping sickness
SCIENCE & TECHNOLOGY2020
sciencescience-technology
New group leader based in Grenoble aims to unveil the mechanisms of RNA editing
PEOPLE & PERSPECTIVES2017
people-perspectivesscience
No results found